The acquired shares are 118,400 common shares, total amount 476,349,928 yen, acquisition period from 2026\/8\/7 to 2026\/8\/31, method is market purchases. The Board of Directors resolution sets a cap of 1,300,000 shares and 6,000,000,000 yen, with a period from 2026\/8\/7 to 2027\/7\/31. The accumulated figures to date fall within this cap.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6859","jir_company_name":"Espice Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-07","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6859-20260907-01.pdf","jir_short_summary":"The acquired shares are 118,400 common shares, total amount 476,349,928 yen, acquisition period from 2026\/8\/7 to 2026\/8\/31, method is market purchases. The Board of Directors resolution sets a cap of 1,300,000 shares and 6,000,000,000 yen, with a period from 2026\/8\/7 to 2027\/7\/31. The accumulated figures to date fall within this cap.","jir_summary":"### Section Heading\nThis notice is a disclosure of treasury stock acquisition status based on the provisions of Article 165 and Article 156 of the Companies Act. The type of shares acquired is our ordinary shares, with a cumulative total of 118,400 shares and a total amount of 476,348,992 yen. The acquisition period is from August 7, 2026 to August 31, 2026, and the acquisition method is market purchases. For reference, on August 6, 2026, the Board resolution set an upper limit of 1,300,000 shares (about 6.07% of issued shares) and 60 billion yen, with a period from August 7, 2026 to July 31, 2027; the current cumulative amount is within that upper limit.\n\n### Section 2 heading\nThis treasury stock acquisition is conducted as part of shareholder returns, and it indicates potential additional acquisitions depending on future market conditions and stock price movements. The acquisition period is restricted, and both the cumulative amount and the number of shares are disclosed within the published upper limits, increasing transparency to shareholders. Note that the text does not detail future capital policy directions or intended use of funds, and only reports the progress of the acquisition itself.","jir_financial_highlights":"Total number of shares acquired: 118,400 shares (Unspecified)\nTotal acquisition value: 476,348,992 yen (Unspecified)\nAcquisition period: 2026 August 7 \u2013 2026 August 31 (Unspecified)\nAcquisition method: Market purchases on the Tokyo Stock Exchange (Unspecified)","jir_category":"","jir_hashtags":"#EspiceShareBuyback, #CapitalPolicy","jir_key_figures":"118,400 shares: Total number of shares acquired\n476,348,992 yen: Total acquisition value\n1,300,000 shares: Upper limit (as of Board resolution)\n60 billion yen: Upper limit acquisition value (as of Board resolution)","jir_meta_title":"\u3010Espice\u3011Notice of treasury stock acquisition status\uff5cAugust 2026","jir_meta_description":"Espice discloses treasury stock acquisition status under the Companies Act. 118,400 shares acquired, total of 476,348,992 yen, period 2026\/8\/7-8\/31, method is market purchases. Upper limits: 1,300,000 shares, 60 billion yen; period 2026\/8\/7-2027\/7\/31.","jir_og_title":"\u3010Espice\u3011Notice of treasury stock acquisition status\uff5cAugust 2026","jir_og_description":"Espice discloses progress of treasury stock acquisition. Cumulative 118,400 shares, total 476,348,992 yen; period 2026\/8\/7-8\/31; method is market purchases. Upper limit is 1,300,000 shares and 60 billion yen.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16866,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-111079","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n